These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 18093483)

  • 1. [Analysis of predictive value of Framingham-REGICOR and SCORE functions in primary health care].
    Buitrago F; Cañón Barroso L; Díaz Herrera N; Cruces E
    Med Clin (Barc); 2007 Dec; 129(20):797. PubMed ID: 18093483
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparison of the SCORE function chart and the Framingham-REGICOR equation to estimate the cardiovascular risk in an urban population after 10 years of follow-up].
    Buitrago Ramírez F; Cañón Barroso L; Díaz Herrera N; Cruces Muro E; Bravo Simón B; Pérez Sánchez I
    Med Clin (Barc); 2006 Sep; 127(10):368-73. PubMed ID: 16987481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Framingham function overestimates the risk of ischemic heart disease in HIV-infected patients from Barcelona.
    Herrera S; Guelar A; Sorlì L; Vila J; Molas E; Grau M; Marrugat J; Esteve E; Güerri-Fernández R; Montero M; Knobel H
    HIV Clin Trials; 2016 Jul; 17(4):131-9. PubMed ID: 27169692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Original and REGICOR Framingham functions in a nondiabetic population of a Spanish health care center: a validation study.
    Buitrago F; Calvo-Hueros JI; Cañón-Barroso L; Pozuelos-Estrada G; Molina-Martínez L; Espigares-Arroyo M; Galán-González JA; Lillo-Bravo FJ
    Ann Fam Med; 2011; 9(5):431-8. PubMed ID: 21911762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Carotid intima-media thickness distribution according to the stratification of cardiovascular risk by means of Framingham-REGICOR and score function charts].
    Hermida-Ameijeiras Á; López-Paz JE; Riveiro-Cruz MA; Calvo-Gómez C
    Hipertens Riesgo Vasc; 2016; 33(2):51-7. PubMed ID: 26796100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Derivation and validation of a set of 10-year cardiovascular risk predictive functions in Spain: the FRESCO Study.
    Marrugat J; Subirana I; Ramos R; Vila J; Marín-Ibañez A; Guembe MJ; Rigo F; Tormo Díaz MJ; Moreno-Iribas C; Cabré JJ; Segura A; Baena-Díez JM; de la Cámara AG; Lapetra J; Grau M; Quesada M; Medrano MJ; González Diego P; Frontera G; Gavrila D; Aicua EA; Basora J; García JM; García-Lareo M; Gutierrez JA; Mayoral E; Sala J; D'Agostino R; Elosua R;
    Prev Med; 2014 Apr; 61():66-74. PubMed ID: 24412897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of the SCORE function chart and the Framingham-REGICOR equation to estimate the cardiovascular risk].
    Cuende JI
    Med Clin (Barc); 2007 Mar; 128(9):358; author reply 358. PubMed ID: 17376368
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparison of the SCORE and REGICOR models for calculating cardiovascular risk in cardiovascular disease-free individuals at a healthcare center in Barcelona, Spain].
    Baena Díez JM; del Val Garcia JL; Héctor Salas Gaetgens L; Sánchez Pérez R; Altes Vaques E; Deixens Martínez B; Amatller Corominas M; Katia Núñez Casillas D
    Rev Esp Salud Publica; 2005; 79(4):453-64. PubMed ID: 16465962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relative validity of the 10-year cardiovascular risk estimate in a population cohort of the REGICOR study].
    Marrugat J; Vila J; Baena-Díez JM; Grau M; Sala J; Ramos R; Subirana I; Fitó M; Elosua R
    Rev Esp Cardiol; 2011 May; 64(5):385-94. PubMed ID: 21482004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation and recalibration of the Framingham cardiovascular disease risk models in an Australian Indigenous cohort.
    Hua X; McDermott R; Lung T; Wenitong M; Tran-Duy A; Li M; Clarke P
    Eur J Prev Cardiol; 2017 Oct; 24(15):1660-1669. PubMed ID: 28749178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adding low ankle brachial index to classical risk factors improves the prediction of major cardiovascular events. The REGICOR study.
    Velescu A; Clara A; Peñafiel J; Ramos R; Marti R; Grau M; Dégano IR; Marrugat J; Elosua R;
    Atherosclerosis; 2015 Aug; 241(2):357-63. PubMed ID: 26071658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of C-reactive protein for cardiovascular risk stratification across three age groups in subjects without existing cardiovascular diseases.
    Hamer M; Chida Y; Stamatakis E
    Am J Cardiol; 2009 Aug; 104(4):538-42. PubMed ID: 19660608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Red cell distribution width and risk of cardiovascular mortality: Insights from National Health and Nutrition Examination Survey (NHANES)-III.
    Shah N; Pahuja M; Pant S; Handa A; Agarwal V; Patel N; Dusaj R
    Int J Cardiol; 2017 Apr; 232():105-110. PubMed ID: 28117138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PROCAM-, FRAMINGHAM-, SCORE- and SMART-risk score for predicting cardiovascular morbidity and mortality in patients with overt atherosclerosis.
    Uthoff H; Staub D; Socrates T; Meyerhans A; Bundi B; Schmid HP; Frauchiger B
    Vasa; 2010 Nov; 39(4):325-33. PubMed ID: 21104622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Estimating cardiovascular risk in Spain using different algorithms].
    Comín E; Solanas P; Cabezas C; Subirana I; Ramos R; Gené-Badía J; Cordón F; Grau M; Cabré-Vila JJ; Marrugat J
    Rev Esp Cardiol; 2007 Jul; 60(7):693-702. PubMed ID: 17663853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiovascular risk in patients with renal failure].
    Calvo Hueros JI; Cañón Barroso L; Gómez Jiménez C; Martín Hidalgo-Barquero MV; Espigares Arroyo M; Buitrago Ramírez F
    Med Clin (Barc); 2008 Jun; 131(2):41-6. PubMed ID: 18588827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Validation of 3 equations of coronary risk in diabetic population of a primary care center].
    Cañón-Barroso L; Cruces-Muro E; Fernández-Ochoa G; Nieto-Hernández T; García-Vellido A; Buitrago F
    Med Clin (Barc); 2006 Apr; 126(13):485-90. PubMed ID: 16624226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Predictive capacity, comparison and clinic consequences of the Framingham-Wilson and REGICOR tables in persons for whom care has been provided at a health care center, Badajoz, Spain].
    Cañón Barroso L; Díaz Herrera N; Cruces Muro E; Nieto Hernández T; Garrote Florencio T; Buitrago F
    Rev Esp Salud Publica; 2007; 81(4):353-64. PubMed ID: 18041538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of Framingham cardiovascular risk scores by ethnic groups in New Zealand: PREDICT CVD-10.
    Riddell T; Wells S; Jackson R; Lee AW; Crengle S; Bramley D; Ameratunga S; Pylypchuk R; Broad J; Marshall R; Kerr A
    N Z Med J; 2010 Feb; 123(1309):50-61. PubMed ID: 20186242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of Framingham general cardiovascular disease risk score for predicting 10-year cardiovascular risk in an Inner Mongolian population: a prospective cohort study.
    Peng H; Jiao Y; Zeng Q; Li H; Zhang M; Wang A; Zhang Y
    Int J Cardiol; 2014 Mar; 172(1):274-5. PubMed ID: 24461982
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.